Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

India Moves To Make HIV/AIDS Drugs More Available

This article was originally published in PharmAsia News

Executive Summary

India is the third-largest country for HIV-positive cases, yet its policy of free drugs to HIV/AIDS patients is not being fulfilled because of the vast distances patients have to travel. Many patients give up treatment because of the distances between places where the drugs are available and the cost of getting to them, even though the country has 147 centers for providing antiretroviral therapy. Some patients have to travel long, arduous distances three times a month for treatment. As a result, the Indian government is looking at "link centers" to bring treatment closer to the patients who need it. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel